---
title: "Sirolimus-eluting Orsiro stent non-inferior to zotarolimus-eluting device in BIOFLOW-DAPT trial"
date: "2023-08-30T10:01:25.000Z"
publishedDate: "30 août 2023"
summary: "One-year-data from the BIOFLOW-DAPT trial demonstrated non-inferiority and a good safety profile for the Orsiro Mission drug-eluting stent (DES) compared to Resolute Onyx DES (Medtronic) in patients at high risk of bleeding receiving short dual antiplatelet therapy (DAPT). Marco Valgimigli (Cardiocentro Ticino Foundation, Lugano, Switzerland) presented the data in a late-breaking trial session at the [&#8230;] The post Sirolimus-eluting Orsiro stent non-inferior to zotarolimus-eluting device in BIOFLOW-DAPT trial appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/bioflow-dapt-one-year/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2023-08-30-sirolimus-eluting-orsiro-stent-non-inferior-to-zotarolimus-eluting-device-in-bioflow-dapt-trial"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/07/orsiro-4-expanded-no-background-1024x901.png"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/bioflow-dapt-one-year/"
---

![Sirolimus-eluting Orsiro stent non-inferior to zotarolimus-eluting device in BIOFLOW-DAPT trial](https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/07/orsiro-4-expanded-no-background-1024x901.png)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/bioflow-dapt-one-year/*

## L’essentiel

One-year-data from the BIOFLOW-DAPT trial demonstrated non-inferiority and a good safety profile for the Orsiro Mission drug-eluting stent (DES) compared to Resolute Onyx DES (Medtronic) in patients at high risk of bleeding receiving short dual antiplatelet therapy (DAPT). Marco Valgimigli (Cardiocentro Ticino Foundation, Lugano, Switzerland) presented the data in a late-breaking trial session at the [&#8230;] The post Sirolimus-eluting Orsiro stent non-inferior to zotarolimus-eluting device in BIOFLOW-DAPT trial appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/bioflow-dapt-one-year/
